Huan Wu
Ji'nan, P.R. China
250012, China
250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis.
Journal: Cell reports
Published: February 06, 2023
Clinical features and prognostic factors analysis of intravenous leiomyomatosis.
Journal: Frontiers in surgery
Published: August 15, 2022
Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer.
Journal: Oncoimmunology
Published: July 08, 2022
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: March 15, 2020
IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer.
Journal: Oncology letters
Published: November 25, 2019
Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma.
Journal: Frontiers in oncology
Published: November 24, 2019
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: October 15, 2019
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Journal: Cell death & disease
Published: October 26, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026